Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction-Reference-Cited by-同舟云学术

Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction

Published:2017-07-21 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Li Jing Wei,Chen Yun Dai,Liu Yu Qi,Wang Jin Da,Chen Wei Ren,Zhang Ying Qian,Ma Qiang

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-06514-3.pdf

Reference43 articles.

1. Haim, M. et al. Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines? American heart journal 147, 859–864, doi: 10.1016/j.ahj.2003.11.014 (2004).

2. St John Sutton, M. et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 89, 68–75, doi: 10.1161/01.cir.89.1.68 (1994).

3. Mulvihill, E. E. & Drucker, D. J. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocrine reviews 35, 992–1019, doi: 10.1210/er.2014-1035 (2014).

4. Zhong, J. & Rajagopalan, S. Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular Disease. Frontiers in immunology 6, doi: 10.3389/fimmu.2015.00477 (2015).

5. Remm, F., Franz, W.-M. & Brenner, C. Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease. European Heart Journal - Cardiovascular Pharmacotherapy 2, 185–193, doi: 10.1093/ehjcvp/pvv044 (2016).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study;Cardiovascular Diabetology;2021-02-02

2. Prevalence, characteristics, and prognostic implications of type 2 diabetes in patients with myocardial infarction: the Polish Registry of Acute Coronary Syndromes (PL‑ACS) annual 2018 report;Kardiologia Polska;2020-03-25

3. Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population;Cardiovascular Drugs and Therapy;2019-08-15

4. Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery;Scientific Reports;2018-08-07